Author Correction: Comprehensive analysis of TLX2 in pan cancer as a prognostic and immunologic biomarker and validation in ovarian cancer

1. These authors contributed equally: Buze Chen and Xiaojuan Ding.

Authors and Affiliations

1. Xuzhou Medical University, Xuzhou, 221004, Jiangsu, China

   Buze Chen, Xiaojuan Ding, Ailing Wan, Xin Qi & Wenyu Mu

2. Cancer Institute, Xuzhou Medical University, No. 209 Tongshan Road, Yunlong District, Xuzhou, 221004, Jiangsu, China

   Buze Chen & Gang Wang

3. Department of Gynecology, The Affiliated Hospital of Xuzhou Medical University, No. 99 West Huaihai Road, Quanshan District, Xuzhou, 221002, Jiangsu, China

   Buze Chen, Xiaoman Lin & Haihong Wang

4. Center of Clinical Oncology, The Affiliated Hospital of Xuzhou Medical University, No. 99 West Huaihai Road, Quanshan District, Xuzhou, 221002, Jiangsu, China

   Gang Wang & Junnian Zheng

5. Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy, Xuzhou Medical University, Xuzhou, 221004, Jiangsu, China

   Gang Wang & Junnian Zheng

Corresponding authors

Correspondence to Buze Chen, Gang Wang or Junnian Zheng.

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions